Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PITPNM2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
TMEM176A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IL2RB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FGFR1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MINCR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
JAM2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KLHL29 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZSWIM5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MAML2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PITRM1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CADM1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TEX22 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SUN1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
USP44 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ADRB1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC40A1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NANOG - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GPR68 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on